Source Code And DCM Co-lead New Round In Chinese AI Pharmaceutical Firm Galixir

Login to View

China’s AI drug research and development platform Galixir has secured nearly US$10 million in a Pre-A round financing co-led by Source Code Capital and DCM.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY